Wrapping up a fascinating conversation led by @kcarterjackson about U.S. violence and the controversial history of violence in defense of black communities and black liberty #Square1Roundtable#reimaginejustice
What impact does violence have on the brain? On personal biology? On families? @EdTalkProject of
University of Chicago urges us to consider why some families struggle more with violence than others. #reimaginejustice.
The best place to locate services to intervene with family violence is in schools, says @EdTalkProject. Why? Because school is already mandatory. But right now schools largely punish kids for their inability to handle structural violence #ReimagineJustice
Should there be licensed mental health workers in schools? Or culturally competenent community members? @EdTalkProject says training teachers is key because they spend the most time with students. Also, it’s often not just one student needing help — but whole classrooms
Why don’t we respond to poor, minority students engaging in violence in the same way we respond to wealthy white students, asks Candice Jones of @PublicWelfare
Bruce Western wrapping up the conservation, focusing on the goal of non-pathologizing language and narrative around violence
By focusing on mental health and resilience, are we just teaching people to tolerate intolerable economic and social conditions, Western asks.
Starting up day 2 of #Square1Roundtable, David Hureau discusses how neighborhood environments enable and constrain violence.
Watch the convo here: bit.ly/2pEPVvQ
Why focus on gun violence specifically? Because, Hureau says, gun violence is a key form of racial inequality, and in communities with high rates of violence it organizes social structure
Current homicide rates are not possible without the mechanical advantage offered by firearms, he says
How do we create laws and accountability for those who are profiting from death, asks Daniel Webster. Consider the massive effort used to track where guns come from when used to shoot police officers but not when used to shoot young black men
Amanda Alexander raises the fundamental issue of public health in the context of gun violence, and how young Chicago advocates successfully advocated for UChicsgo to open a trauma facility to treat victims of gun violence
Micere Keels follows up by questioning the American notion of individuals having to pay for medical services
Bruce Western wrapping up the conversation about the racialization of gun policy and the fact the the gun industry has effectively captured gun regulation
Now Beth Richie of @UChicago is talking about the cycle of harm and trauma that stems from coping with violence, with a specific focus on women #reimaginejustice#addressingviolence
How do we confront gender based violence and domestic violence without feeding mass incarceration? That’s a big question in this conversation.
“I don’t think gender violence goes down when black men go down” says Richie.
Richie: You can’t rely on the state to do a project that’s about liberation.
Discussing Eric Garner in an economic perspective: Garner was killed at a location being developed and gentrified, which thusly brought in police to impose zero tolerance.
And why was Garner selling loose cigarettes? Post-2008 economic crisis led to NYC raising taxes on cigarettes, making them unaffordable and creating a black market
New members join the Roundtable to talk about policies being implemented in Detroit to reduce violence. The historical trends in municipal budgets have tilted towards policing and corrections, yet there is a growing movement to reframe what truly makes the community safe.
Saturday’s Roundtable begins with a reflection on the last two days, with a focus on the language used.
Currently discussing how people don’t want to be labeled “oppressed” or “at risk.”
Now @DanielWWebster1 is discussing policies relating to guns, alcohol, drugs, and housing that have significant impact and implications for violence in the U.S.
44% of people sentenced to jail have a diagnosed mental illness
63% have a substance use disorder
45% suffer from chronic health problems
Jail often makes these conditions worse.
So how should cities respond to people in crisis? With data-driven justice. 1/
Today @Arnold_Ventures released the final reports from a multiyear pilot site test of using coordination and data to divert people in crisis away from jails and toward the services they need, such as healthcare or housing. 2/
These documents are three years in the making. Each site released its own final report that delves into how they used power of data to understand and better address the needs of frequent utilizers. 3/
As the nation grapples with unemployment & state budgets shrink amid #COVID-19, Nevada has a model that policy officials could implement and test to reemploy dislocated workers: It’s helping millions find jobs faster AND saving state money. arnoldventures.org/stories/nevada…#VPDebates
“I’m so grateful for #Gleevec. It keeps me alive. But the price tag ($10k/month) constantly hangs over my head.”
"When I'm on Enbrel, I don't have symptoms... But I also have to carry the fear knowing all this could be ripped away." Enbrel is priced at $6k per month.
First up: autoimmune drug Enbrel. Even though the primary patent on Enbrel expired in 2010, $AMGN has filed more than 50 additional patents on the drug to thwart cheaper competition, according to analysis by @IMAKglobal (1/) statnews.com/2020/09/29/dru…
Medicare spent hundreds of millions of $$$ more on Copaxone each year because of its inability to negotiate directly @46brooklyn@akesselheim
Even Teva’s own employees could not afford Copaxone at its price. One said she could no longer afford Copaxone because she would have to pay $1,673.33 out of pocket as compared to $12 for Mylan’s generic product.
After Mylan introduced a lower-priced generic version of Copaxone 40 mg/ml in October 2017, Teva implemented several new exclusionary tactics to limit generic competition and maintain profits.
First up: #Revlimid, a drug that costs $20k for a 28-day supply. The Committee reviewed more than 50k pages of internal communications & data from 2009 to now. Since Revlimid launched in '05, Celgene raised the price 22 times (1/) oversight.house.gov/sites/democrat…
After Bristol Myers Squibb obtained the rights to Revlimid last November, it raised the price again to $763/pill. The price has tripled in 15 years (2/)
Revlimid is a textbook case of profits over patients (3/)